Concordia

Department of Health written question – answered on 12th December 2017.

Alert me about debates like this

Photo of Lloyd Russell-Moyle Lloyd Russell-Moyle Labour/Co-operative, Brighton, Kemptown

To ask the Secretary of State for Health, what steps he plans to take against Concordia as a result of the Competition and Markets Authority findings announced on 21 November 2017 that Concordia had overcharged the NHS for the provision of Liothyronine tablets.

Photo of Steve Brine Steve Brine The Parliamentary Under-Secretary of State for Health

The Competition and Markets Authority has provisionally found that Concordia abused its dominant position to overcharge the National Health Service by millions for liothyronine tablets. A provisional decision does not necessarily lead to an infringement decision. Where companies have breached competition law, the Department will seek damages and invest that money back into the NHS.

Does this answer the above question?

Yes2 people think so

No1 person thinks not

Would you like to ask a question like this yourself? Use our Freedom of Information site.